- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06468163
Efficacy of Local Antibiotic Injection Via a Catheter for Treating Acute Periprosthetic Infections After Knee DAIR Surgery (YES)
Efficacy of Local Antibiotic Injection Via a Catheter for Treating Acute Periprosthetic Infections After Knee DAIR Surgery: A Prospective, Randomized Controlled Trial Study
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Long Hua, M.D.
- Phone Number: +8615099182364
- Email: hualong_xmu@163.com
Study Contact Backup
- Name: Li Cao, M.D.
- Phone Number: +8613909915960
- Email: xjbone@sina.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥18 years old, gender is not limited;
- Meet the diagnostic criteria for DAIR surgery of artificial knee joint;
- Receiving knee DAIR surgery;
- Voluntary and signed informed consent.
Exclusion Criteria:
- Patients with chronic PJI infection undergoing total knee revision;
- Patients with severe knee joint infection who cannot undergo artificial joint replacement;
- Progressive renal insufficiency (stage 4 and above) or glomerular filtration rate less than 30ml/min;
- periprosthesis infection after multiple joint replacement;
- Active infection at the site of intravenous or joint injection;
- long-term use of anticoagulants or antiplatelet drugs due to other diseases;
- Have sepsis or positive blood culture within the last 30 days;
- Radiotherapy and chemotherapy are required due to neoplastic diseases;
- Receiving systemic glucocorticoid therapy (prednisone > 10mg/ day or equivalent hormone medication);
- severe immunodeficiency diseases (such as stage 3 HIV, sickle cell anemia, splenectomy, etc.);
- Have a history of drug abuse;
- Treatment of bone marrow or other transplants with immunosuppressive drugs;
- Pregnant, parturient and lactating women;
- Participating in other clinical trials;
- Researchers believe that other reasons are not appropriate for clinical trial participants.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Catheter group
Using catheter after knee DAIR surgery.
|
With or without using catheter after DAIR operation for drug infusion.
|
Active Comparator: None-catheter group
Without using catheter after knee DAIR surgery.
|
With or without using catheter after DAIR operation for drug infusion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infection control rate
Time Frame: Two year after surgery
|
Infection control rate
|
Two year after surgery
|
Time between infection recurrence
Time Frame: Two year after surgery
|
Time between infection recurrence
|
Two year after surgery
|
Re-operation rate
Time Frame: Two year after surgery
|
Re-operation rate
|
Two year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
X-ray
Time Frame: One day before surgery and two years after surgery
|
X-ray
|
One day before surgery and two years after surgery
|
American Knee Society Score (AKS score)
Time Frame: One day before surgery and two years after surgery
|
American Knee Society Score is used to evaluate the outcomes of knee replacement surgery. This scoring system consists of two main components: the knee score and the function score. Knee Score: This primarily assesses the condition of the knee joint itself, including pain, stability, and range of motion. The higher of the score, the better of the functional result. |
One day before surgery and two years after surgery
|
Redness, Edema, Ecchymosis, Discharge, and Approximation score (REEDA score)
Time Frame: One day before surgery, three month after surgery
|
The REEDA score is a clinical tool used to assess the healing of perineal wounds and other skin wounds, particularly after childbirth.
REEDA stands for Redness, Edema, Ecchymosis, Discharge, and Approximation.
Each of these five parameters is scored on a scale from 0 to 3, with higher scores indicating more severe symptoms.
The total REEDA score can range from 0 to 15.
|
One day before surgery, three month after surgery
|
Visual Analog Scale score
Time Frame: One day before surgery and two years after surgery
|
The VAS score, or Visual Analog Scale, is a tool commonly used to measure a person's level of pain.
The VAS is a simple, subjective measure that consists of a straight line, typically 10 centimeters long, anchored by two endpoints.
One end of the line represents "no pain" and the other end represents "worst pain imaginable."
For example, if the VAS line is 10 cm long and the patient's mark is at 7 cm from the "no pain" end, their pain score would be 7 out of 10.
|
One day before surgery and two years after surgery
|
White blood cell count
Time Frame: One day before surgery and one day after surgery
|
White blood cell count from blood
|
One day before surgery and one day after surgery
|
Erythrocyte sedimentation rate (ESR)
Time Frame: One day before surgery and one day after surgery
|
It measures the rate at which red blood cells settle to the bottom of a test tube within one hour. Normal ranges: Male: 0 to 15 millimeters per hour (mm/hr) Female: 0 to 20 millimeters per hour (mm/hr) |
One day before surgery and one day after surgery
|
C-reactive protein (CRP)
Time Frame: One day before surgery and one day after surgery
|
C-reactive protein (CRP) is a protein produced by the liver that significantly increases in response to inflammation or infection.
Normal range for CRP is less than 10 milligrams per liter (mg/L).
|
One day before surgery and one day after surgery
|
Synovial fluid white blood count
Time Frame: One day before surgery and one day after surgery
|
Synovial fluid white blood count
|
One day before surgery and one day after surgery
|
Polymorphonuclear neutrophil percentage in synovial fluid (SF-PMN)
Time Frame: One day before surgery and one day after surgery
|
Polymorphonuclear neutrophil percentage in synovial fluid refers to the proportion or percentage of polymorphonuclear neutrophils (PMN) present in the synovial fluid.
This measurement is important in the assessment of joint health and inflammation, particularly in conditions such as arthritis and infections affecting the joints.
Normal range: Less than 80%.
|
One day before surgery and one day after surgery
|
Alanine Aminotransferase (ALT)
Time Frame: One day before surgery and one day after surgery
|
An enzyme found in the liver that helps convert proteins into energy.
Elevated levels indicate liver damage.
Normal range: 10 to 40 units per liter (U/L)
|
One day before surgery and one day after surgery
|
Aspartate Aminotransferase (AST)
Time Frame: One day before surgery and one day after surgery
|
An enzyme found in the liver and other tissues.
High levels can indicate liver damage but are less specific than ALT.
Normal range: 10 to 40 units per liter (U/L)
|
One day before surgery and one day after surgery
|
Serum Creatinine
Time Frame: One day before surgery and one day after surgery
|
Measures the level of creatinine in the blood.
Elevated levels can indicate impaired kidney function.
Normal range: 62 to 115 micromoles per liter (µmol/L).
|
One day before surgery and one day after surgery
|
Blood Urea Nitrogen (BUN)
Time Frame: One day before surgery and one day after surgery
|
Measures the amount of nitrogen in the blood that comes from urea.
Elevated BUN levels can indicate impaired kidney function.
Normal range: 2.5 to 7.1 millimoles per liter (mmol/L).
|
One day before surgery and one day after surgery
|
Collaborators and Investigators
Investigators
- Study Chair: Li Cao, M.D., The first affliated hospital, Xinjiang medical university
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HL240528-12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug infusion into joint through catheter.
-
Medtronic Cardiac Rhythm and Heart FailureUnited TherapeuticsActive, not recruitingPulmonary Arterial HypertensionUnited States
-
Massachusetts General HospitalTerminatedHepatitis C | Respiratory FailureUnited States
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI); University of WashingtonActive, not recruitingPeripheral Artery Disease | Critical Limb Ischemia | Vascular DiseaseUnited States
-
Hospital Universitario La FeRecruitingCesarean Section | Post Operative Pain | Quality of Recovery | Postoperative Recovery | Ondansetron | Tramadol | QoR-15 | ObsQor-10 | Postcesarean RecoverySpain